ROXO 150

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Kupite ga zdaj

Navodilo za uporabo Navodilo za uporabo (PIL)
13-04-2022
Javno poročilo o oceni Javno poročilo o oceni (PAR)
25-08-2021

Aktivna sestavina:

ROXITHROMYCIN

Dostopno od:

UNIPHARM LTD, ISRAEL

Koda artikla:

J01FA06

Farmacevtska oblika:

TABLETS

Sestava:

ROXITHROMYCIN 150 MG

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

UNIPHARM LTD, ISRAEL

Terapevtsko območje:

ROXITHROMYCIN

Terapevtske indikacije:

For the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ENT bronchopulmonary, genital and skin manifestations.

Datum dovoljenje:

2021-08-31

Navodilo za uporabo

                                PATIENT PACKAGE INSERT IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
)PREPARATIONS( – 1986
The medicine is dispensed with
a doctor’s prescription only
ROXO 150
TABLETS
ACTIVE INGREDIENT:
Each tablet contains:
Roxithromycin 150 mg
Inactive and allergenic ingredients in the preparation –
see section 6 (Further information) and section 2
(Before using the medicine).
Read the leaflet carefully in its entirety before using
the medicine. Keep this leaflet; you may need to read
it again.
THIS LEAFLET CONTAINS CONCISE INFORMATION ABOUT
THE MEDICINE. If you have further questions, refer to
the doctor or pharmacist.
This medicine has been prescribed for you. Do not
pass it on to others. It may harm them even if it seems
to you that their medical condition is similar.
1.
WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for the treatment of
infections caused by bacteria susceptible to
roxithromycin, such as infections of the respiratory
tract, including nose, ear and throat, infections of the
skin and genitals.
THERAPEUTIC GROUP: Macrolide antibiotic.
2.
BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE:
•
If you are sensitive )allergic( to roxithromycin or to
any of the additional ingredients contained in the
medicine )see section 6 “Further information”(,
or to another macrolide antibiotic )e.g.,
erythromycin(.
•
If you are being treated concomitantly with ergot
derivatives )for treatment of migraine(, such as
ergotamine and dihydroergotamine.
• If you are being treated concomitantly with
colchicine (to treat gout).
• If you are being treated concomitantly with
medicines such as: cisapride (for treatment of
reflux ]gastroesophageal reflux[(, pimozide )a
neuroleptic medicine) or medicines for treatment
of allergies containing terfenadine or astemizole.
• When you are breastfeeding and your baby is
being treated with the medicine cisapride (see
PREGNANCY AND BREASTFEEDING section).
If you are taking other medicines, confirm that there is
no contraindication for combined use with ROXO 150
(s
                                
                                Preberite celoten dokument
                                
                            

Dokumenti v drugih jezikih

Navodilo za uporabo Navodilo za uporabo arabščina 13-04-2022
Navodilo za uporabo Navodilo za uporabo hebrejščina 13-04-2022

Opozorila o iskanju, povezana s tem izdelkom

Ogled zgodovine dokumentov